SCHEMBL4358256

SCHEMBL4358256

CC(C)(C)NC(=S)Nc1cc(Br)cc(F)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.47
POLB P06746 2/20 0.42
ALDH1A1 P00352 7/20 0.40
MAPT P10636 5/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TNF P01375 1/20 0.40
NOD2 Q9HC29 1/20 0.40
NOD1 Q9Y239 1/20 0.40
ALOX12 P18054 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
LMNA P02545 4/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
HPGD P15428 2/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350392 0.85 HTT (0.44) HTTPOLBALDH1A1MAPTGAA
SCHEMBL4354426 0.82 NPC1 (0.47) HTTPOLBALDH1A1MAPTGAA
SCHEMBL4351728 0.79 LMNA (0.38) HTTALDH1A1MAPTKDM4ENPSR1
SCHEMBL4353358 0.76 HTT (0.50) HTTPOLBALDH1A1MAPTGAA
SCHEMBL12362248 0.75 PDK1 (0.39) HTTALDH1A1GAAKDM4ESMN1; SMN2
SCHEMBL4346266 0.75 POLB (0.48) HTTPOLBALDH1A1MAPTGAA
SCHEMBL4348536 0.75 LMNA (0.69) HTTALDH1A1MAPTGAAKDM4E
SCHEMBL27761072 0.74 SMN1; SMN2 (0.57) HTTALDH1A1MAPTGAAALOX12
SCHEMBL4357679 0.74 MAOB (0.51) HTTALDH1A1MAPTNPSR1ALOX12
SCHEMBL4349397 0.73 SMN1; SMN2 (0.52) HTTALDH1A1MAPTALOX12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 HTT 3824/4885POLB 3571/4885ALDH1A1 2565/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 HTT 3995/4885POLB 2402/4885ALDH1A1 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.